These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34053779)

  • 21. Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes.
    Dianat SS; Carter HB; Pienta KJ; Schaeffer EM; Landis PK; Epstein JI; Trock BJ; Macura KJ
    Urology; 2015 Jan; 85(1):147-53. PubMed ID: 25440986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Clinical Significance of Multiple Negative Surveillance Prostate Biopsies for Men on Active Surveillance-Does Cancer Vanish or Simply Hide?
    Chu CE; Cowan JE; Fasulo V; Washington SL; de la Calle C; Shoemaker J; Carroll PR
    J Urol; 2021 Jan; 205(1):109-114. PubMed ID: 33198555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transperineal Prostate Biopsy Improves the Detection of Clinically Significant Prostate Cancer among Men on Active Surveillance.
    Meyer AR; Mamawala M; Winoker JS; Landis P; Epstein JI; Macura KJ; Allaf ME; Partin AW; Pavlovich CP; Gorin MA
    J Urol; 2021 Apr; 205(4):1069-1074. PubMed ID: 33487007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.
    Nassiri N; Margolis DJ; Natarajan S; Sharma DS; Huang J; Dorey FJ; Marks LS
    J Urol; 2017 Mar; 197(3 Pt 1):632-639. PubMed ID: 27639713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study.
    Ullrich T; Arsov C; Quentin M; Mones F; Westphalen AC; Mally D; Hiester A; Albers P; Antoch G; Schimmöller L
    Eur Radiol; 2020 Nov; 30(11):6042-6051. PubMed ID: 32591887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer.
    Maggi M; Cowan JE; Fasulo V; Washington SL; Lonergan PE; Sciarra A; Nguyen HG; Carroll PR
    J Urol; 2020 Dec; 204(6):1222-1228. PubMed ID: 33157570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design.
    Ahlberg MS; Adami HO; Beckmann K; Bertilsson H; Bratt O; Cahill D; Egevad L; Garmo H; Holmberg L; Johansson E; Rannikko A; Van Hemelrijck M; Jäderling F; Wassberg C; Åberg UWN; Bill-Axelson A
    BMJ Open; 2019 Aug; 9(8):e027860. PubMed ID: 31444180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Importance of Being PRECISE in Prostate Magnetic Resonance Imaging and Active Surveillance.
    Giganti F; Kasivisvanathan V; Allen C; Moore CM
    Eur Urol; 2021 Apr; 79(4):560-563. PubMed ID: 33546915
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer.
    Chu CE; Lonergan PE; Washington SL; Cowan JE; Shinohara K; Westphalen AC; Carroll PR; Cooperberg MR
    Eur Urol; 2020 Oct; 78(4):515-517. PubMed ID: 32631744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer.
    Fujihara A; Iwata T; Shakir A; Tafuri A; Cacciamani GE; Gill K; Ashrafi A; Ukimura O; Desai M; Duddalwar V; Stern MS; Aron M; Palmer SL; Gill IS; Abreu AL
    BJU Int; 2021 Jun; 127(6):712-721. PubMed ID: 33043575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Magnetic Resonance Imaging/Ultrasound-Fusion Biopsy in Patients with Low-Risk Prostate Cancer Under Active Surveillance Undergoing Surveillance Biopsy.
    Borkowetz A; Renner T; Platzek I; Toma M; Herout R; Baunacke M; Groeben C; Huber J; Laniado M; Baretton GB; Froehner M; Zastrow S; Wirth MP
    Urol Int; 2018; 100(2):155-163. PubMed ID: 29339663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance.
    Curci NE; Lane BR; Shankar PR; Noyes SL; Moriarity AK; Kubat A; Brede C; Montgomery JS; Auffenberg GB; Miller DC; Montie JE; George AK; Davenport MS
    Urology; 2018 Jun; 116():137-143. PubMed ID: 29653121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-based approach to active surveillance of prostate cancer.
    Witherspoon L; Breau RH; Lavallée LT
    World J Urol; 2020 Mar; 38(3):555-562. PubMed ID: 30726506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Super active surveillance for low-risk prostate cancer | Opinion: No.
    Ghodoussipour S; Lebastchi AH; Bloom JB; Pinto PA; Berger A
    Int Braz J Urol; 2019; 45(2):215-219. PubMed ID: 31021585
    [No Abstract]   [Full Text] [Related]  

  • 35. [Active surveillance of prostate cancer : An update].
    Chaloupka M; Westhofen T; Kretschmer A; Grimm T; Stief C; Apfelbeck M
    Urologe A; 2019 Mar; 58(3):329-340. PubMed ID: 30824971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Magnetic Resonance Imaging in Active Surveillance (MRIAS) Trial: Use of Baseline Multiparametric Magnetic Resonance Imaging and Saturation Biopsy to Reduce the Frequency of Surveillance Prostate Biopsies.
    Amin A; Scheltema MJ; Shnier R; Blazevski A; Moses D; Cusick T; Siriwardena A; Yuen B; van Leeuwen PJ; Haynes AM; Matthews J; Brenner P; O'Neill G; Yuen C; Delprado W; Stricker P; Thompson J
    J Urol; 2020 May; 203(5):910-917. PubMed ID: 31825297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?
    Roscigno M; Stabile A; Lughezzani G; Pepe P; Galosi AB; Naselli A; Naspro R; Nicolai M; La Croce G; Aljoulani M; Perugini G; Guazzoni G; Montorsi F; Balzarini L; Sironi S; Da Pozzo LF
    Clin Genitourin Cancer; 2020 Dec; 18(6):e698-e704. PubMed ID: 32493676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer.
    Vargas HA; Akin O; Afaq A; Goldman D; Zheng J; Moskowitz CS; Shukla-Dave A; Eastham J; Scardino P; Hricak H
    J Urol; 2012 Nov; 188(5):1732-8. PubMed ID: 23017866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of MRI in active surveillance for men with localized prostate cancer.
    Recabal P; Ehdaie B
    Curr Opin Urol; 2015 Nov; 25(6):504-9. PubMed ID: 26372037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Contemporary Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Prostate Cancer.
    Schulman AA; Sze C; Tsivian E; Gupta RT; Moul JW; Polascik TJ
    Curr Urol Rep; 2017 Jul; 18(7):52. PubMed ID: 28589398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.